Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

PETMED Aktie

 >PETMED Aktienkurs 
1.994 EUR    (TradegateBSX)
Ask: 2.003 EUR / 830 Stück
Bid: 1.985 EUR / 840 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
PETMED Aktie über LYNX handeln
>PETMED Performance
1 Woche: +0,1%
1 Monat: -15,0%
3 Monate: -29,4%
6 Monate: -10,7%
1 Jahr: -42,8%
laufendes Jahr: -30,9%
>PETMED Aktie
Name:  PETMED EXPRESS
Land:  USA
Sektor:  Handel
ISIN/ Wkn:  US7163821066 / 121843
Symbol/ Ticker:  PQM (Frankfurt) / PETS (NASDAQ)
Kürzel:  FRA:PQM, ETR:PQM, PQM:GR, NASDAQ:PETS
Index:  -
Webseite:  https://investors.petmeds..
Profil:  PetMed Express Inc. is a leading retailer in the pet medication and health products industry. The company specializes in delivering prescription and non-prescription pet medications directly to customers, predominantly serving the pet owners' market ..
>Volltext..
Marktkapitalisierung:  43.75 Mio. EUR
Unternehmenswert:  21.41 Mio. EUR
Umsatz:  158.25 Mio. EUR
EBITDA:  -17.34 Mio. EUR
Nettogewinn:  -56.2 Mio. EUR
Gewinn je Aktie:  -2.7 EUR
Schulden:  0.56 Mio. EUR
Liquide Mittel:  23.32 Mio. EUR
Operativer Cashflow:  -14.41 Mio. EUR
Bargeldquote:  0.49
Umsatzwachstum:  -34.82%
Gewinnwachstum:  -16115.66%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  11.08.23 - 0.2574€
05.06.23 - 0.2574€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  PETMED, PETMEDS
Letzte Datenerhebung:  05.04.26
>PETMED Kennzahlen
Aktien/ Unternehmen:
Aktien: 21.4 Mio. St.
Frei handelbar: 68.68%
Rückkaufquote: -
Mitarbeiter: 173
Umsatz/Mitarb.: 1.14 Mio. EUR
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 0.26
KBV: 1.57
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 25.28%
Gewinnmarge: -35.51%
Operative Marge: -15.9%
Managementeffizenz:
Gesamtkaprendite: -55.74%
Eigenkaprendite: -100.61%
>PETMED Peer Group
Handel
 
12.02.26 - 12:42
Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways (Accesswire)
 
MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disc......
01.01.26 - 16:06
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS (PR Newswire)
 
NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
16.12.25 - 18:36
PetMed Express: Aktie schießt nach Übernahmeangebot von Cardone Ventures in die Höhe (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
16.12.25 - 18:24
PetMed Express jumps on $4.25/share takeover offer from Cardone Ventures (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.12.25 - 18:06
Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express (Business Wire)
 
MIAMI--(BUSINESS WIRE)--Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (Nasdaq: PETS) (“PetMeds”) for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivered to the Board of Directors of PetMed Express and is not subject to any financing contingency, reflecting Cardone Ventures' confidence in its ability to execute the transaction. Strategic Rationale Cardone Ventures views PetMeds as a strategically important acquisition that aligns with its core mission of acquiring, operating, and scaling businesses with strong brands and meaningful growth potential. PetMeds' national pet pharmacy platform, customer relationships, fulfillment infrastructure, and regulatory capabilities present a compelling opportunity for operational enhancement under private ownership. Cardon...
11.12.25 - 15:48
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited (GlobeNewswire EN)
 
No Stockholder Action Required at this Time No Stockholder Action Required at this Time...
11.12.25 - 15:18
Übernahmeangebot von 4 US-Dollar pro Aktie beflügelt PetMed Express (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.12.25 - 14:39
PetMed Express jumps on $4/share takeover offer SilverCape Investments (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.12.25 - 14:03
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them (GlobeNewswire EN)
 
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds' giftable assortment focuses on products that improve pets' everyday health, comfort, safety, and happiness, making them ideal for the pet owner who has everything....
28.11.25 - 21:06
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses to Contact the Firm (PR Newswire)
 
NEWTOWN, Pa., Nov. 28, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving PetMed Express, Inc. (NASDAQ: PETS), resulting from allegations of providing potentially misleading business information to the investing public.......
26.11.25 - 22:31
PetMed Express: Aktie legt nach Verlängerung des Aktionärsrechteplans zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
26.11.25 - 22:06
PetMeds Extends Existing Shareholder Rights Plan (GlobeNewswire EN)
 
DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company's existing shareholder rights plan (the “Rights Plan”), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan remain unchanged....
20.11.25 - 16:06
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS (PR Newswire)
 
NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
20.10.25 - 14:33
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair (GlobeNewswire EN)
 
Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls...
14.10.25 - 22:18
PetMeds® Files Form 10-K for Fiscal 2025 (GlobeNewswire EN)
 
DELRAY BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the fiscal year ended March 31, 2025....
10.10.25 - 14:42
PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman (PR Newswire)
 
SAN FRANCISCO, Oct. 10, 2025 /PRNewswire/ -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company announced it would not timely file its annual financial statements for its year ended March 31,......
08.10.25 - 22:09
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
DELRAY BEACH, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS), today announced that on September 9, 2025, the Compensation and Human Capital Committee of the Board of Directors approved an award of 15,000 shares of restricted common stock to Ali Khan, the Company's newly hired Chief Information Security Officer, as a material inducement to employment....
16.08.25 - 16:15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS (PR Newswire)
 
NEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
14.08.25 - 17:01
Insiderhandel: Insider kauft Aktien von PetMed Express im Wert von 320170 USD (Insiderkauf)
 
Silvercape Investments Ltd - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-08-13...
12.08.25 - 22:42
PetMed Express CEO and CFO resign; board chair named interim CEO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!